Affiliations
Free PMC article
Item in Clipboard
Viruses.
.
Free PMC article
Abstract
The current SARS-CoV-2 pandemic forms a major global health burden. Although protective vaccines are available, concerns remain as new virus variants continue to appear. CRISPR-based gene-editing approaches offer an attractive therapeutic strategy as the CRISPR-RNA (crRNA) can be adjusted rapidly to accommodate a new viral genome sequence. This study aimed at using the RNA-targeting CRISPR-Cas13d system to attack highly conserved sequences in the viral RNA genome, thereby preparing for future zoonotic outbreaks of other coronaviruses. We designed 29 crRNAs targeting highly conserved sequences along the complete SARS-CoV-2 genome. Several crRNAs demonstrated efficient silencing of a reporter with the matching viral target sequence and efficient inhibition of a SARS-CoV-2 replicon. The crRNAs that suppress SARS-CoV-2 were also able to suppress SARS-CoV, thus demonstrating the breadth of this antiviral strategy. Strikingly, we observed that only crRNAs directed against the plus-genomic RNA demonstrated antiviral activity in the replicon assay, in contrast to those that bind the minus-genomic RNA, the replication intermediate. These results point to a major difference in the vulnerability and biology of the +RNA versus -RNA strands of the SARS-CoV-2 genome and provide important insights for the design of RNA-targeting antivirals.
Keywords:
COVID-19; CRISPR-Cas13d; RNA; SARS-CoV-2 genome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics.
Exp Biol Med (Maywood). 2021 Jul;246(14):1643-1649. doi: 10.1177/15353702211008106. Epub 2021 Apr 25.
Exp Biol Med (Maywood). 2021.PMID: 33899542
Free PMC article.Review.
-
In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack.
Viruses. 2022 Feb 14;14(2):385. doi: 10.3390/v14020385.
Viruses. 2022.PMID: 35215977
Free PMC article. -
A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.
Med Hypotheses. 2022 Feb;159:110754. doi: 10.1016/j.mehy.2021.110754. Epub 2022 Jan 4.
Med Hypotheses. 2022.PMID: 35002020
Free PMC article. -
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
Cell. 2020 May 14;181(4):865-876.e12. doi: 10.1016/j.cell.2020.04.020. Epub 2020 Apr 29.
Cell. 2020.PMID: 32353252
Free PMC article. -
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
Drug Resist Updat. 2020.PMID: 33132205
Free PMC article.Review.
References
MeSH terms
LinkOut – more resources
-
Full Text Sources
-
Medical
-
Miscellaneous
Read more here: Source link